Anterior Tilted Deployment of EVOQUE Transcatheter Tricuspid Valve Replacement System: Overcoming Inadequate Implant Depth
Abstract
Transcatheter tricuspid valve (TV) replacement (TTVR) with the EVOQUE system is the first and only Food and Drug Administration-approved replacement option for patients with ≥ moderate tricuspid regurgitation despite optimal medical therapy. Several anatomical considerations affect procedural success. Transfemoral (TF) access is the preferred approach but can be challenging. It is influenced by the inferior vena cava (IVC)-to-tricuspid valve annulus (TVA) offset as well as the working room length. The latter combines right atrium (RA) height and right ventricle (RV) depth and is affected by the IVC-TVA distance. In cases where the right atrial height is short (
Fields of Study & Subjects
Cardiac Valve Diseases and Treatments
Aortic Disease and Treatment Approaches
Congenital Heart Disease Studies
Publication details
- Journal / source
- Structural Heart
- Publisher
- Elsevier BV
- Volume
- 10
- Issue
- 7
- Pages
- 100816–100816
- Publication date
- 9 February 2026
- Language
- EN